Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?

Neurodegenerative disease management - United Kingdom
doi 10.2217/nmt.12.75
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd